|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.011 EUR | +0.18% |
|
+9.26% | -15.71% |
| 06-16 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
| 04-28 | Clinuvel Pharmaceuticals plans level II ADR upgrade and Nasdaq listing as CUVL | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.42% | -0.40% | -4.13% | -16.42% | -20.65% | +20.16% | -21.46% | +14.70% | +74.05% | 62.32B | |
| +0.69% | -0.28% | +1.92% | +0.28% | +4.48% | +51.64% | +197.92% | +201.31% | +281.89% | 53.94B | |
| -5.75% | +29.50% | +29.50% | +29.50% | +29.50% | +29.50% | +29.50% | +29.50% | - | 38.98B | |
| -0.74% | +5.45% | +13.78% | -19.85% | -35.11% | -53.47% | -60.27% | -61.92% | +2.76% | 37.89B | |
| +1.59% | +0.54% | +3.07% | +10.06% | +13.48% | +57.20% | -32.06% | -46.66% | -14.87% | 29.48B | |
| -7.22% | +13.84% | +26.59% | +15.50% | +101.24% | +129.13% | -50.74% | -73.19% | - | 23.55B | |
| +5.54% | +1.65% | +6.69% | +14.19% | +4.95% | +51.42% | +67.44% | +21.82% | +32.05% | 20.71B | |
| +1.66% | +0.13% | -4.20% | -1.29% | +0.33% | -3.04% | +151.23% | -15.05% | - | 16.71B | |
| +2.25% | +5.86% | +1.88% | +26.56% | +36.90% | +64.60% | +119.04% | +207.84% | +337.24% | 16.02B | |
| +4.00% | +1.35% | -0.29% | +0.55% | -9.90% | +65.16% | +327.01% | +14.22% | - | 13.5B | |
| -1.06% | -2.19% | +5.03% | +57.95% | +35.70% | +146.15% | +174.32% | +248.30% | +3,466.19% | 12.75B | |
| -0.85% | +0.43% | -3.84% | -0.85% | -22.02% | -10.13% | +721.81% | +437.85% | +6,305.08% | 12.21B | |
| +2.21% | +0.45% | +3.35% | +3.27% | -5.94% | +1.64% | -41.53% | -31.11% | -31.98% | 10.8B | |
| -1.33% | +5.75% | +14.69% | +36.46% | +39.30% | +159.27% | +186.31% | +424.32% | - | 10.12B | |
| -0.41% | -0.69% | -7.30% | +2.04% | -16.00% | -11.27% | -21.60% | -59.62% | -54.14% | 6.28B | |
| -2.73% | +5.42% | +40.61% | +102.45% | +168.51% | +145.87% | +380.64% | -28.30% | - | 5.3B | |
| +0.35% | +0.99% | -21.86% | -28.72% | -36.27% | -53.84% | -57.00% | -77.24% | - | 5.35B | |
| +2.69% | +6.38% | -3.26% | -14.63% | +0.36% | +11.10% | +259.92% | +176.52% | - | 5.46B | |
| +1.99% | -0.55% | -10.24% | -23.55% | -32.22% | -25.16% | +126.38% | +38.66% | +109.06% | 5.13B | |
| Average | +0.15% | +1.27% | +4.84% | +10.18% | +13.51% | +40.84% | +129.31% | +74.84% | +955.21% | 20.34B | |
| Weighted average by Cap. | -0.23% | +0.71% | +6.51% | +5.41% | +7.96% | +37.62% | +83.90% | +61.83% | +547.96% |
- Stock Market
- Stocks
- CUV Stock
- UR9 Stock
- Sector Clinuvel Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
